Trial Outcomes & Findings for Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology (NCT NCT05116163)
NCT ID: NCT05116163
Last Updated: 2025-11-12
Results Overview
Documented receipt of high-quality care at the appointment or within 30 days of the appointment. The quality metrics for Lupus and RA include but are not limited to: Hydroxychloroquine (HCQ) initiation and Folic acid if receiving methotrexate, respectively. These items will be added together to form a score and the number of items completed out of the total will be the primary outcome measure compared across groups. The denominator is the patient-specific quality metrics they are eligible for and the numerator is the number achieved. The final percent ranges from 0-100 (with 100 indicating that 100% of the quality metrics that the patient was eligible for were met).
COMPLETED
NA
201 participants
30 days
2025-11-12
Participant Flow
Rheumatologists were recruited from 6/17/2022-12/12/2023 at Brigham and Women's Hospital and Massachusetts General Hospital.
Rheumatologists took Implicit Association Tests and were provided with implicit bias training and then randomized to either the control or intervention arm.
Participant milestones
| Measure |
Arm 1: Rheumatologist Individuation Intervention Plus Implicit Bias Education
Rheumatologists were randomized to this arm. They first watched implicit bias educational modules and then were instructed to incorporate an individuation strategy into each of their clinical encounters. Rheumatologists were given a choice of several individuation-related questions to better understand the unique characteristics of each patient. Once the provider decided on his/her choice phrases, the research team assisted with the development of a smart phrase (also called "dot phrase") to allow them to incorporate this into a note. Once a week, rheumatologists received an email reminding them to incorporate this question and the documentation into their encounters.
|
Arm 2: Rheumatologist Implicit Bias Education Only
Rheumatologists were randomized to this arm. They watched implicit bias educational modules (same as those used in Arm 1) and received no further intervention.
|
Patients of Arm 1 Providers- Chart Review Only
Patients of providers randomized to Arm 1 (individuation intervention). These patients were not intervened upon; their charts from routine care were reviewed only if they met inclusion criteria.
|
Patients of Arm 2 Providers- Chart Review Only
Patients of providers randomized to Arm 2. These patients were not intervened upon; their charts from routine care were reviewed only if they met inclusion criteria.
|
Patients of Arm 1 Rheumatologists Enrolled for Audiorecording
Patients of rheumatologists randomized to Arm 1 who consented for audiorecording and completed surveys, and participated in chart reviews.
|
Patients of Arm 2 Rheumatologists Enrolled for Audiorecording
Patients of rheumatologists randomized to Arm 2 who consented for audiorecording and completed surveys, and participated in chart reviews.
|
|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
10
|
9
|
81
|
54
|
20
|
27
|
|
Overall Study
COMPLETED
|
10
|
9
|
79
|
50
|
19
|
27
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
2
|
4
|
1
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
Baseline characteristics by cohort
| Measure |
Arm 1: Individuation Intervention Plus Implicit Bias Education: Rheumatologists
n=10 Participants
Rheumatologists watched implicit bias training modules and then were instructed to incorporate an individuation strategy into each of their clinical encounters.
|
Arm 2: Implicit Bias Education Only: Rheumatologists
n=9 Participants
Rheumatologists watched implicit bias training modules.
|
Patients of Arm 1- Chart Review Only
n=79 Participants
Patients of providers in Arm 1 who had their electronic health records reviewed but did not enroll/complete surveys
|
Patients of Arm 2- Chart Review Only
n=50 Participants
Patients of providers in Arm 2 who had their electronic health records reviewed but did not enroll/complete surveys
|
Patients of Arm 1 Providers With Audiorecordings and Surveys
n=20 Participants
Patients of providers in Arm 1 who enrolled for an audiorecorded encounter and surveys
|
Patients of Arm 2 Providers With Audiorecordings and Surveys
n=27 Participants
Patients of providers in Arm 2 who enrolled for an audiorecorded encounter and surveys
|
Total
n=195 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|
|
Sex/Gender, Customized
Female
|
5 Participants
n=10 Participants
|
5 Participants
n=9 Participants
|
53 Participants
n=79 Participants
|
37 Participants
n=50 Participants
|
11 Participants
n=20 Participants
|
17 Participants
n=27 Participants
|
128 Participants
n=195 Participants
|
|
Sex/Gender, Customized
Male
|
5 Participants
n=10 Participants
|
4 Participants
n=9 Participants
|
6 Participants
n=79 Participants
|
4 Participants
n=50 Participants
|
4 Participants
n=20 Participants
|
2 Participants
n=27 Participants
|
25 Participants
n=195 Participants
|
|
Age, Categorical
<=18 years
|
0 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=79 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=195 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=10 Participants
|
8 Participants
n=9 Participants
|
53 Participants
n=79 Participants
|
38 Participants
n=50 Participants
|
17 Participants
n=20 Participants
|
23 Participants
n=27 Participants
|
148 Participants
n=195 Participants
|
|
Age, Categorical
>=65 years
|
1 Participants
n=10 Participants
|
1 Participants
n=9 Participants
|
26 Participants
n=79 Participants
|
12 Participants
n=50 Participants
|
3 Participants
n=20 Participants
|
4 Participants
n=27 Participants
|
47 Participants
n=195 Participants
|
|
Sex/Gender, Customized
Unknown
|
0 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
20 Participants
n=79 Participants
|
9 Participants
n=50 Participants
|
5 Participants
n=20 Participants
|
8 Participants
n=27 Participants
|
42 Participants
n=195 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=10 Participants
|
3 Participants
n=9 Participants
|
9 Participants
n=79 Participants
|
10 Participants
n=50 Participants
|
2 Participants
n=20 Participants
|
5 Participants
n=27 Participants
|
29 Participants
n=195 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
9 Participants
n=10 Participants
|
6 Participants
n=9 Participants
|
67 Participants
n=79 Participants
|
38 Participants
n=50 Participants
|
17 Participants
n=20 Participants
|
21 Participants
n=27 Participants
|
158 Participants
n=195 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
3 Participants
n=79 Participants
|
2 Participants
n=50 Participants
|
1 Participants
n=20 Participants
|
1 Participants
n=27 Participants
|
8 Participants
n=195 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=79 Participants
|
1 Participants
n=50 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=27 Participants
|
1 Participants
n=195 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=10 Participants
|
2 Participants
n=9 Participants
|
0 Participants
n=79 Participants
|
0 Participants
n=50 Participants
|
1 Participants
n=20 Participants
|
0 Participants
n=27 Participants
|
4 Participants
n=195 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=79 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=195 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=10 Participants
|
1 Participants
n=9 Participants
|
61 Participants
n=79 Participants
|
37 Participants
n=50 Participants
|
14 Participants
n=20 Participants
|
23 Participants
n=27 Participants
|
136 Participants
n=195 Participants
|
|
Race (NIH/OMB)
White
|
8 Participants
n=10 Participants
|
6 Participants
n=9 Participants
|
10 Participants
n=79 Participants
|
6 Participants
n=50 Participants
|
3 Participants
n=20 Participants
|
4 Participants
n=27 Participants
|
37 Participants
n=195 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
2 Participants
n=79 Participants
|
1 Participants
n=50 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=27 Participants
|
3 Participants
n=195 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=10 Participants
|
0 Participants
n=9 Participants
|
6 Participants
n=79 Participants
|
5 Participants
n=50 Participants
|
2 Participants
n=20 Participants
|
0 Participants
n=27 Participants
|
14 Participants
n=195 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=10 Participants
|
9 participants
n=9 Participants
|
79 participants
n=79 Participants
|
50 participants
n=50 Participants
|
20 participants
n=20 Participants
|
27 participants
n=27 Participants
|
248 participants
n=195 Participants
|
|
Provider-Only Implicit Association Test- Race Bias
|
-0.46 units on a scale
STANDARD_DEVIATION 0.54 • n=10 Participants • This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
|
-0.37 units on a scale
STANDARD_DEVIATION 0.57 • n=9 Participants • This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
|
—
|
—
|
—
|
—
|
-0.42 units on a scale
STANDARD_DEVIATION 0.54 • n=19 Participants • This analysis was only completed for providers; therefore the number analyzed for each of the patient categories is 0.
|
|
Provider-Only Implicit Association Tests - Race stereotyping
|
-0.13 units on a scale
STANDARD_DEVIATION 0.76 • n=10 Participants • Provider only surveys
|
-0.29 units on a scale
STANDARD_DEVIATION 0.37 • n=9 Participants • Provider only surveys
|
—
|
—
|
—
|
—
|
-0.20 units on a scale
STANDARD_DEVIATION 0.60 • n=19 Participants • Provider only surveys
|
|
Provider-Only Implicit Association Test - Socioeconomic status bias
|
0.75 units on a scale
STANDARD_DEVIATION 0.55 • n=10 Participants • Provider only surveys
|
0.54 units on a scale
STANDARD_DEVIATION 0.35 • n=9 Participants • Provider only surveys
|
—
|
—
|
—
|
—
|
0.65 units on a scale
STANDARD_DEVIATION 0.47 • n=19 Participants • Provider only surveys
|
|
Provider-Only Implicit Association Test - Socioeconomic status stereotyping
|
0.54 units on a scale
STANDARD_DEVIATION 0.60 • n=10 Participants • Provider only surveys
|
0.48 units on a scale
STANDARD_DEVIATION 0.49 • n=9 Participants • Provider only surveys
|
—
|
—
|
—
|
—
|
0.51 units on a scale
STANDARD_DEVIATION 0.54 • n=19 Participants • Provider only surveys
|
|
Baseline Medication Adherence
|
—
|
—
|
—
|
—
|
49.3 units on a scale
STANDARD_DEVIATION 19.6 • n=20 Participants • Enrolled patient-only measure
|
58.9 units on a scale
STANDARD_DEVIATION 18.8 • n=27 Participants • Enrolled patient-only measure
|
53.8 units on a scale
STANDARD_DEVIATION 19.5 • n=47 Participants • Enrolled patient-only measure
|
PRIMARY outcome
Timeframe: 30 daysPopulation: Patients of providers randomized to Arm 1 or Arm 2, which includes the eligible patients in the chart-review groups, and those who also participated in the audiorecordings and surveys
Documented receipt of high-quality care at the appointment or within 30 days of the appointment. The quality metrics for Lupus and RA include but are not limited to: Hydroxychloroquine (HCQ) initiation and Folic acid if receiving methotrexate, respectively. These items will be added together to form a score and the number of items completed out of the total will be the primary outcome measure compared across groups. The denominator is the patient-specific quality metrics they are eligible for and the numerator is the number achieved. The final percent ranges from 0-100 (with 100 indicating that 100% of the quality metrics that the patient was eligible for were met).
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Percent of Quality Metrics Achieved
|
62.14 Percent of Quality Metrics Achieved
Standard Deviation 13.46
|
54.31 Percent of Quality Metrics Achieved
Standard Deviation 14.46
|
SECONDARY outcome
Timeframe: At time of appointment (baseline) during which audiorecording took place, reflecting the experience at the appointment immediately preceding survey completion.Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.
Differences in perception of patient centeredness comparing the intervention to non-intervention group. Higher scores indicate less patient-centered experiences. 4-point Likert scale, score range from 14-56.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=21 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Perception of Patient Centeredness
|
27.5 score on a scale
Standard Deviation 9
|
23.4 score on a scale
Standard Deviation 7
|
SECONDARY outcome
Timeframe: At time of appointment (baseline) during which audiorecording took place, reflecting the experience at the appointment immediately preceding survey completion.Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.
Differences in patient satisfaction score, comparing the intervention to non-intervention group. Score range from 20-70. Higher scores indicate greater patient satisfaction.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=17 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=22 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Patient Satisfaction
|
50.4 score on a scale
Standard Deviation 9
|
51.5 score on a scale
Standard Deviation 8
|
SECONDARY outcome
Timeframe: A time of the appointment when audiorecording took place (baseline) asking patients to describe the degree to which each item occurs in their day-to-day life.Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.
Reflects experiences of everyday discrimination, comparing the intervention to non-intervention group. Score range is 0-40. Higher scores indicate a greater amount of discrimination encountered.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=25 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Everyday Discrimination Scale
|
0.96 score on a scale
Standard Deviation 0.84
|
1.16 score on a scale
Standard Deviation 0.93
|
SECONDARY outcome
Timeframe: 3 months after the start of the interventionPopulation: Subset of patients in the audiorecording/survey arms who returned completed 3 month follow up adherence surveys.
Adherence score (for rheumatology medications), comparing the 3-month adherence score to baseline for the intervention to non-intervention group at three months following the encounter date. Score range is 0-100 with zero being the lowest adherence, and 100 being the best.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=13 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=12 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Adherence
|
54.96 score on a scale
Standard Deviation 14.15
|
55.99 score on a scale
Standard Deviation 19.44
|
SECONDARY outcome
Timeframe: One time baseline evaluation from the transcript of the audiorecording of the encounter of the patient with their rheumatologistPopulation: Patients who participated in audiorecordings and had transcripts for analysis.
Provider communication will be measured using the recorded transcripts and compared between arms. We compared the mean (SD) of provider positive emotion words expressed during a clinical encounter. Measured only for patients enrolled in the study who had their appointment audiorecorded.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=27 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Provider Communication: Positive Emotion Words
|
0.99 Number of words
Standard Deviation 0.50
|
0.66 Number of words
Standard Deviation 0.33
|
SECONDARY outcome
Timeframe: One time baseline evaluation after the appointment reflecting experiences at the immediately preceding appointment.Population: Subset of patients who consented to participate in audiorecordings and returned completed surveys.
Patient trust in their providers, comparing the intervention to non-intervention group. Responses are summed (range 5-25) with higher scores indicating more trust.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=19 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=24 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Patient Trust
|
16.4 score on a scale
Standard Deviation 4
|
17.6 score on a scale
Standard Deviation 5
|
SECONDARY outcome
Timeframe: 6 months following the encounter of interestComparison of incidence rate of Emergency Department visits between patients of providers in the intervention compared to the control arms.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Incidence Rate Ratio of Emergency Departments Visits
|
0.398 number of ED visits
Standard Deviation 0.971
|
0.390 number of ED visits
Standard Deviation 0.934
|
SECONDARY outcome
Timeframe: 6 months following the encounter of interestComparison of incidence rate of outpatient visits between patients of providers in the intervention compared to the control arms.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Incidence Rate Ratio of Outpatient Visits.
|
7.34 Number of outpatient visits
Standard Deviation 6.22
|
6.05 Number of outpatient visits
Standard Deviation 5.88
|
SECONDARY outcome
Timeframe: 6 months after physician encounterComparison of incidence rate of hospitalizations between patients of providers in the intervention compared to the control arms.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=98 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=77 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Incidence Rate Ratio of Hospitalizations
|
0.316 number of hospitalizations
Standard Deviation 1.06
|
0.779 number of hospitalizations
Standard Deviation 0.354
|
SECONDARY outcome
Timeframe: Baseline compared to 6 months after the start of the intervention.Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-high socioeconomic status bias and a score of -1 is pro-low socioeconomic status bias.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Implicit Association Test (IAT) Scores- Socioeconomic Status Stereotyping
|
0.50 units on a scale
Standard Deviation 0.37
|
0.15 units on a scale
Standard Deviation 0.50
|
SECONDARY outcome
Timeframe: Baseline compared to 6 months after the start of the intervention.Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-White bias and a score of -1 is pro-Black bias.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Implicit Association Test (IAT) Scores- Race Implicit Bias
|
-0.27 units on a scale
Standard Deviation 0.47
|
0.12 units on a scale
Standard Deviation 0.44
|
SECONDARY outcome
Timeframe: Baseline compared to 6 months after the start of the intervention.Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-White stereotyping and a score of -1 is pro-Black stereotyping.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Implicit Association Test (IAT) Scores- Race Stereotyping.
|
-0.25 units on a scale
Standard Deviation 0.61
|
-0.39 units on a scale
Standard Deviation 0.50
|
SECONDARY outcome
Timeframe: Baseline compared to 6 months after the start of the intervention.. Change in provider IAT scores pre and post intervention. IAT scores range from -1 to 1. A score of 0 indicates no strong implicit bias. A score of 1 is pro-high socioeconomic status bias and a score of -1 is pro-low socioeconomic status bias.
Outcome measures
| Measure |
Patients of Arm 1 Providers Enrolled for Audiorecording and Surveys
n=10 Participants
Subset of patients of providers in Arm 1 who enrolled for audiorecordings and completed surveys
|
Patients of Arm 2 Providers Enrolled for Audiorecording and Surveys
n=9 Participants
Subset of patients of providers in Arm 2 who enrolled in audiorecording and completed surveys
|
|---|---|---|
|
Implicit Association Test (IAT) Scores- Socioeconomic Status Bias
|
0.48 units on a scale
Standard Deviation 0.37
|
0.60 units on a scale
Standard Deviation 0.56
|
Adverse Events
Patients of Arm 1 Providers- Chart Review Only
Patients of Arm 2 Providers- Chart Review Only
Arm 1 Patients Enrolled for Audiorecording
Arm 2 Patients Enrolled for Audiorecording
Arm 1: Individuation Intervention Plus Implicit Bias Education
Arm 2: Implicit Bias Education Only
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place